SLC12A6 Gene Agenesis of the corpus callosum with peripheral neuropathy Genetic Test
Are you or a loved one experiencing symptoms of agenesis of the corpus callosum with peripheral neuropathy (ACCPN)? DNA Labs UAE offers a comprehensive genetic test to help diagnose this rare condition.
Test Details
The SLC12A6 gene is associated with ACCPN, a genetic condition characterized by the absence or underdevelopment of the corpus callosum and peripheral neuropathy. Our genetic test utilizes Next-Generation Sequencing (NGS) technology to analyze the entire SLC12A6 gene for any mutations or variations that may be causing the condition.
Test Components and Price
- Test Name: SLC12A6 Gene Agenesis of the corpus callosum with peripheral neuropathy Genetic Test
- Price: 3200.0 AED
Sample Condition
We accept blood samples, extracted DNA, or one drop of blood on an FTA card.
Report Delivery
Reports are typically delivered within 2 to 4 weeks.
Test Type
This test falls under the category of Neurological Disorders.
Referring Doctor
Our genetic test is conducted under the supervision of a qualified Neurologist.
Test Department
Our Genetics department handles all aspects of this test.
Pre Test Information
Prior to the test, we recommend a genetic counseling session to gather clinical history and draw a pedigree chart of family members affected by ACCPN.
Why Choose Our Test?
Our SLC12A6 Gene Agenesis of the corpus callosum with peripheral neuropathy Genetic Test provides valuable information about the cause of ACCPN. With this knowledge, healthcare professionals can develop effective treatment and management strategies for affected individuals and their families.
| Test Name | SLC12A6 Gene Agenesis of the corpus callosum with peripheral neuropathy Genetic Test |
|---|---|
| Components | |
| Price | 3200.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 25 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for SLC12A6 Gene Agenesis of the corpus callosum with peripheral neuropathy NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SLC12A6 Gene Agenesis of the corpus callosum with peripheral neuropathy |
| Test Details | The SLC12A6 gene is associated with a rare genetic condition called agenesis of the corpus callosum with peripheral neuropathy (ACCPN). This condition is characterized by the absence or underdevelopment of the corpus callosum, a structure that connects the two hemispheres of the brain, and peripheral neuropathy, which is a disorder of the nerves that transmit information from the brain and spinal cord to the rest of the body. NGS genetic testing can be used to detect mutations in the SLC12A6 gene, which can help diagnose ACCPN. This test involves sequencing the entire SLC12A6 gene to identify any changes or variations that may be causing the condition. The results of this test can provide important information about the cause of ACCPN and can help guide treatment and management strategies for affected individuals and their families. |
